Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia.
Suo X, Ma X, Zheng F, Wang D, Bai G, Zhao L, Han Z, Lv X, Zhang C, Wang J, Tuo K, Meng Z, Liu S, Gao S, Zhang J, Jiao Z, Song J, Li L, Lu X, Yuan L, Liu K, Zhao X, Mi Y.
Suo X, et al. Among authors: zhao x.
Blood Cancer J. 2024 Nov 20;14(1):204. doi: 10.1038/s41408-024-01189-2.
Blood Cancer J. 2024.
PMID: 39567479
No abstract available.